Cite
HARVARD Citation
Gravina, G. et al. (2015). KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models. BMC cancer. 15 (1), pp. 1-19. [Online].